NFKB1 and psoriasis: Treg-of-B cells inhibit NLRP3 inflammasome activation by inhibiting NF-κB signaling, inducing STAT6 phosphorylation in macrophages, and promoting M2 macrophage polarization, thereby improving psoriasis symptoms and reducing inflammation [100].